AU8629691A - Method for treating the premenstrual or late luteal phase syndrome - Google Patents

Method for treating the premenstrual or late luteal phase syndrome

Info

Publication number
AU8629691A
AU8629691A AU86296/91A AU8629691A AU8629691A AU 8629691 A AU8629691 A AU 8629691A AU 86296/91 A AU86296/91 A AU 86296/91A AU 8629691 A AU8629691 A AU 8629691A AU 8629691 A AU8629691 A AU 8629691A
Authority
AU
Australia
Prior art keywords
premenstrual
treating
luteal phase
phase syndrome
late luteal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU86296/91A
Other languages
English (en)
Inventor
Judith J. Wurtman
Richard J. Wurtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Massachusetts Institute of Technology
Original Assignee
Massachusetts Institute of Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/565,046 external-priority patent/US5223540A/en
Application filed by Massachusetts Institute of Technology filed Critical Massachusetts Institute of Technology
Publication of AU8629691A publication Critical patent/AU8629691A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU86296/91A 1990-08-09 1991-08-09 Method for treating the premenstrual or late luteal phase syndrome Abandoned AU8629691A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US565046 1990-08-09
US07/565,046 US5223540A (en) 1987-10-22 1990-08-09 Method for treating the premenstrual or late luteal phase syndrome
US65073491A 1991-02-05 1991-02-05
US650734 1996-05-20

Publications (1)

Publication Number Publication Date
AU8629691A true AU8629691A (en) 1992-03-02

Family

ID=27073741

Family Applications (1)

Application Number Title Priority Date Filing Date
AU86296/91A Abandoned AU8629691A (en) 1990-08-09 1991-08-09 Method for treating the premenstrual or late luteal phase syndrome

Country Status (4)

Country Link
AU (1) AU8629691A (pt)
IE (1) IE912826A1 (pt)
PT (1) PT98628A (pt)
WO (1) WO1992002215A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1256085C (zh) 1997-07-01 2006-05-17 美国辉瑞有限公司 舍曲林盐和舍曲林的缓释剂型
US10675280B2 (en) 2001-10-20 2020-06-09 Sprout Pharmaceuticals, Inc. Treating sexual desire disorders with flibanserin
UA78974C2 (en) 2001-10-20 2007-05-10 Boehringer Ingelheim Pharma Use of flibanserin for treating disorders of sexual desire
PL1912650T3 (pl) 2005-08-03 2018-01-31 Sprout Pharmaceuticals Inc Zastosowanie flibanseryny w leczeniu otyłości
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
US20090312242A1 (en) 2006-06-30 2009-12-17 Ramiro Castro Flibanserin for the treatment of urinary incontinence and related diseases
CL2007002214A1 (es) 2006-08-14 2008-03-07 Boehringer Ingelheim Int Composicion farmaceutica en la forma de comprimido, donde al menos la longitud del comprimido en el estado anterior de la aplicacion es al menos 7/12 del diametro pilorico del paciente y despues de ingerirlo en estado alimentado, la longitud del comp
CN104721168A (zh) 2006-08-25 2015-06-24 贝林格尔·英格海姆国际有限公司 控制释放系统及其制造方法
UY31335A1 (es) 2007-09-12 2009-04-30 Tratamiento de sintomas vasomotores

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4452815A (en) * 1980-06-16 1984-06-05 Massachusetts Institute Of Technology Method of utilizing d,l-fenfluramine for modifying feeding behavior
US4309445A (en) * 1980-06-16 1982-01-05 Massachusetts Institute Of Technology d-Fenfluramine for modifying feeding behavior
US4590213A (en) * 1983-04-08 1986-05-20 Eli Lilly And Company Anti-anxiety method
US4649161A (en) * 1986-06-16 1987-03-10 Massachusetts Institute Of Technology Method for treating depression with d-fenfluramine
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline

Also Published As

Publication number Publication date
PT98628A (pt) 1992-06-30
WO1992002215A1 (en) 1992-02-20
IE912826A1 (en) 1992-02-12

Similar Documents

Publication Publication Date Title
AU6194094A (en) Sweetener, process for the preparation thereof and the use thereof
EP0632022A3 (en) Process for the preparation of amino-substituted thioethers.
EP0643155A3 (en) Process for the preparation of fluorinated chemical compounds.
AU7125191A (en) Process for preparing dimethylnaphthalene
AU645063B2 (en) Process for preparing 1,1,1,2-tetrafluoroethane
AU8629691A (en) Method for treating the premenstrual or late luteal phase syndrome
EP0597329A3 (de) Verfahren zur Herstellung von alpha-Fluor -beta-dicarbonylverbindungen.
SG46689A1 (en) Process for the preparation of 2-h-heptafluoropropane
AU4445893A (en) Process for the purification of 1,1,1,2-tetrafluoroethane
EP0622384A3 (de) Verfahren zur Herstellung von Polymerpolyesterolen.
AU3213593A (en) Process for the preparation of 1,1,1,2-tetrafluoroethane
AU1077992A (en) Process for preparing 1,3-dioxols
EP0628536A3 (de) Verfahren zur Herstellung von Aminen.
IL110425A0 (en) Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidines
ZA928865B (en) Process for preparing daunorubicin.
EP0634389A3 (de) Verfahren zur Herstellung von Dialkylcarbonaten.
EP0635482A3 (de) Verfahren zur Herstellung von mehrfach fluorierten Nitrobenzolen.
PH31154A (en) Process for preparing 1-alkylryl-2-alkyl-5-formyl-imidazole.
GB9416728D0 (en) Process for the preparation of 4-chloro-2-cyclopropylcarhbonylaniline
ZA929873B (en) Process for the manufacture of 2-alkoxymethylacrolein.
EP1017395A4 (en) METHOD FOR TREATING THE PRESENTIAL OR LATE-PHASE SYNDROME
GR3024856T3 (en) Process for the preparation of dichloroacetylchloride.
EP0621264A3 (de) Verfahren zur Herstellung von 4-Alkanoaryl-benzylethern.
EP0635481A3 (de) Verfahren zur Herstellung von Fluornitrobenzolen.
EP0635486A3 (de) Verfahren zur Herstellung von Fluorbenzonitrilen.